SOLICITATION NOTICE
A -- A Solicitationn of the NIH and the CDC for Small Business Innovation Research Contract Proposals
- Notice Date
- 7/13/2007
- Notice Type
- Solicitation Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, MD, 20892-7902, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- PHS-2008-1
- Response Due
- 11/5/2007
- Archive Date
- 11/20/2007
- Small Business Set-Aside
- Total Small Business
- Description
- National Institutes of Health, Bethesda, MD 20892 and Centers for Disease Control and Prevention, Atlanta, GA 30305 are soliciting proposals from small business concerns that possess the research and development (R&D) expertise to conduct innovative research that will contribute toward meeting the program objectives of the agencies. A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH CONTRACT PROPOSALS [PHS 2008-1], with a closing date of November 5, 2007, for receipt of proposals, soon will be available electronically through the NIH Small Business Funding Opportunities home page at http://grants.nih.gov/grants/funding/sbir.htm. The SBIR Phase I Contract Solicitation will only be available via electronic means. Printed copies of the solicitation will not be distributed. Potential offerors are encouraged to check the NIH SBIR/STTR home page for updates on the program. Any updates or corrections to the solicitation will be posted there. The SBIR program, which was initiated in 1982, was reauthorized through fiscal year 2008 by the Small Business Innovation Research Program Reauthorization Act of 2000 (Public Law 106-554; December 21, 2000). The purposes of the Act are to: (a) expand and improve the SBIR program; (b) emphasize increased private sector commercialization of technology developed through federal R&D; (c) increase small business participation in federal R&D; and (d) foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in the SBIR program. For purposes of the SBIR program, a small business concern is any business concern that, on the date of award, (1) is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor; (2) is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there can be no more than 49 percent participation by foreign business entities in the joint venture; (3) is at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States; or is owned and controlled by another (one) small business concern that is itself at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States ; AND (4) has, including its affiliates, no more than 500 employees. Following are the research topics identified in the NIH/CDC SBIR Contract Solicitation [PHS 2008-1]: NATIONAL CANCER INSTITUTE (NCI): Antibody Array For Cancer; Biosensors for Early Cancer Detection And Risk Assessment; Novel And Improved Methods To Measure Cancer Epigenetic Biomarkers; Integrating Patient-Reported Outcomes In Hospice And Palliative Care Practices; Portable E-Technology Tools for Real-Time Energy Balance Research; Patient-Centered Coordinated Cancer Care System; System To Analyze And Support Biomarker Research And Development Strategies; Biopsy Instruments And Devices That Preserve Molecular Profiles In Tumors; Development of Molecular Pharmacodynamic Assays for Targeted Therapies; Development of Anticancer Agents; Nanotechnology Imaging And Sensing Platforms for Improved Diagnosis of Cancer; Multifunctional Therapeutics Based On Nanotechnology; Advances In Protein Expression of Post-Translationally Modified Cancer Related Proteins; Development of Clinical Quantitative Multiplex High-Throughput Mass Spectrometric Immunoassay for Detecting Low Abundance Cancer Related Proteins/Peptides In Bodily Fluids; High Throughput Assays for Isolation and Characterization of Cancer Stem Cells; Assay Systems for Drug Efficacy in Cancer Stem Cells. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI): Production of Generic Modified Hemoglobin; Aged Animal Resources for Cardiovascular Disease Research; Nanoprobes for Non-Invasive Detection of Atherosclerotic Plaques; Cardiovascular, Lung, And Blood Computational Model Library; Refinement and Standardization of a Parvovirus B19 Vaccine; Development of Pathogen Inactivation Technologies for Blood Components. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA): Alcohol Biosensors and Data Analysis Systems; Biomarkers for Alcohol-Induced Disorders; Medications Development to Treat Alcohol Use Disorders and Alcohol Related Medical Disorders; Development of Methodology for Measuring and Enhancing Compliance for Medications. NATIONAL INSTITUTE ON DRUG ABUSE (NIDA): Develop a Real-Time fMRI Feedback System that Allows Drug Abusers to Control their Cravings and Urges and/or Increase their Self-Control of their Drug Taking; Design and Synthesis of Treatment Agents for Drug Abuse; Development of Website Training on Addiction Medicine for Pain Management Providers; Development of Web-based Skills Training for Primary Care Physicians on Screening, Brief Intervention, Referral and Treatment; Drug Abuse Screening, Assessment, Patient-Treatment Matching Technologies for Use in Primary Care; Tools to Measure Intervention Costs, Cost Effectiveness, and Net Economic Benefits; Development of Nanoscience-based Probes, Delivery Systems, and Therapies for Substance Use Disorders; Discovery and Study of Psychoactive Components of Botanicals. NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH): Development and Evaluation of Tools to Enhance the Dissemination of Educational Information Intended Specifically for Autism Caregivers; Multi-Media Training for Social Workers in Evidence-Based Mental Health Practices and Psychotherapies. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) - NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES (NCBDDD): Maximize Quality and Quantity of DNA from Mailed Cytobrushes. COORDINATING OFFICE FOR TERRORISM PREPAREDNESS AND EMERGENCY RESPONSE (COTPER): Environmental Monitoring Systems for Forward Placed Assets. IMMUNIZATION SAFETY OFFICE (ISO): Novel or Enhanced Methods for Vaccination via the Respiratory Tract; Novel or Enhanced Methods for Cutaneous Vaccination; Novel or Enhanced Methods for Vaccination by Jet Injection. The NIH/CDC SBIR Contract Solicitation PHS 2008-1, including proposal forms, soon will be available electronically through the NIH Small Business Funding Opportunities Web site at http://grants.nih.gov/grants/funding/sbir.htm. (Note: The PHS 2007-2 Omnibus Solicitation of the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) GRANT APPLICATIONS is still open and is available at the same Web site noted above with remaining closing dates of August 5 and December 5, 2007.) LINKURL: http://grants.nih.gov/grants/funding/sbir.htm LINKDESC: National Institutes of Health Small Business (SBIR/STTR) Funding Opportunities. E-mail: sbir@od.nih.gov Point of Contact Office of Extramural Programs, Office of Extramural Research, National Institutes of Health, Phone 301-435-2688, sbir@od.nih.gov Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, Rockledge Dr., Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr., RKL2/6100 MSC 7902, Bethesda, MD, 20892-7902
- Record
- SN01341729-W 20070715/070713220651 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |